VolitionRX Ltd
General ticker "VNRX" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $55.6M
VolitionRX Ltd does not follow the US Stock Market performance with the rate: -28.5%.
Estimated limits based on current volatility of 6.3%: low 0.60$, high 0.68$
Factors to consider:
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.48$, 1.36$]
- 2024-12-30 to 2025-12-30 estimated range: [0.50$, 1.41$]
Financial Metrics affecting the VNRX estimates:
- Negative: Non-GAAP EPS, $ of -0.51 <= 0.10
- Negative: Operating profit margin, % of -97.89 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -26.83 <= 2.35
- Positive: Inventory ratio change, % of 0.04 <= 1.08
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Negative: Industry earnings per price (median), % of -6.44 <= 1.31
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
Short-term VNRX quotes
Long-term VNRX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.09MM | $0.31MM | $0.78MM |
| Operating Expenses | $28.42MM | $32.09MM | $36.76MM |
| Operating Income | $-28.33MM | $-31.78MM | $-35.99MM |
| Non-Operating Income | $1.34MM | $1.18MM | $0.31MM |
| Interest Expense | $0.16MM | $0.17MM | $0.22MM |
| R&D Expense | $15.54MM | $14.57MM | $19.55MM |
| Income(Loss) | $-26.99MM | $-30.60MM | $-35.68MM |
| Taxes | $-0.02MM | $-0.33MM | $-0.36MM |
| Profit(Loss) | $-26.97MM | $-30.27MM | $-35.32MM |
| Stockholders Equity | $17.72MM | $-3.13MM | $-7.80MM |
| Inventory | $0.60MM | $0.78MM | $0.00MM |
| Assets | $27.49MM | $18.30MM | $27.95MM |
| Operating Cash Flow | $-20.85MM | $-15.28MM | $-18.06MM |
| Capital expenditure | $0.97MM | $1.57MM | $1.08MM |
| Investing Cash Flow | $-0.97MM | $-1.57MM | $-1.08MM |
| Financing Cash Flow | $22.86MM | $6.94MM | $28.98MM |
| Earnings Per Share* | $-0.51 | $-0.55 | $-0.50 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.